Literature DB >> 10453351

Glutamine: establishing clinical indications.

R D Griffiths1.   

Abstract

Glutamine, a non-essential amino acid, is abundant in the human body and in the food we eat; it is mainly produced in skeletal muscle and acts as a major inter-organ nitrogen and carbon transporter. Its importance to the metabolism is evident during stress, when it becomes a conditionally essential amino acid when endogenous supply fails to meet increased demands. During the past 2 years, an increased understanding has been gained into the role of glutamine in metabolism. A number of new clinical studies of glutamine supplementation have shown interesting outcomes that should be influencing clinical decision-making.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453351     DOI: 10.1097/00075197-199903000-00015

Source DB:  PubMed          Journal:  Curr Opin Clin Nutr Metab Care        ISSN: 1363-1950            Impact factor:   4.294


  5 in total

1.  Glutamine: a life-threatening deficiency in the critically ill?

Authors:  R D Griffiths; F Andrews
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

Review 2.  Immune-modulating enteral formulations: optimum components, appropriate patients, and controversial use of arginine in sepsis.

Authors:  Minhao Zhou; Robert G Martindale
Journal:  Curr Gastroenterol Rep       Date:  2007-08

3.  Fragmentation pathway for glutamine identification: loss of 73 Da from dimethylformamidine glutamine isobutyl ester.

Authors:  Qingfen Zhang; Vicki H Wysocki; Patricia Y Scaraffia; Michael A Wells
Journal:  J Am Soc Mass Spectrom       Date:  2005-07       Impact factor: 3.109

4.  Evolution of the Maillard Reaction in Glutamine or Arginine-Dextrinomaltose Model Systems.

Authors:  Silvia Pastoriza; José Ángel Rufián-Henares; Belén García-Villanova; Eduardo Guerra-Hernández
Journal:  Foods       Date:  2016-12-07

Review 5.  Chronic Critical Illness and PICS Nutritional Strategies.

Authors:  Martin D Rosenthal; Erin L Vanzant; Frederick A Moore
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.